Literature DB >> 31541750

Research letter: Effectiveness of canakinumab for the treatment of Yao syndrome patients.

Qingping Yao1.   

Abstract

Entities:  

Year:  2019        PMID： 31541750     DOI： 10.1016/j.jaad.2019.09.020

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  2 in total

Review 1.  New insights on multigenic autoinflammatory diseases.

Authors:  Petros Efthimiou; Olga Petryna; Priscila Nakasato; Apostolos Kontzias
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-03       Impact factor: 3.625

2.  Treatment of refractory Yao syndrome with canakinumab.

Authors:  Caroline J Brailsford; Fatima Khamdan; Dirk M Elston
Journal:  JAAD Case Rep       Date:  2022-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.